Frequent occurrence of protein isoforms with or without a single amino acid residue by subtle alternative splicing:: the case of Gln in DRPLA affects subcellular localization of the products

被引:52
作者
Tadokoro, K
Yamazaki-Inoue, M
Tachibana, M
Fujishiro, M
Nagao, K
Toyoda, M
Ozaki, M
Ono, M
Miki, N
Miyashita, T
Yamada, M
机构
[1] Natl Res Inst Child Hlth & Dev, Setagaya Ku, Tokyo 1578535, Japan
[2] Tokyo Med Univ, Dept Pediat, Tokyo, Japan
[3] Nihon Univ, Lab Nucl Acid Sci, Fujisawa, Kanagawa, Japan
[4] Brain Sci Inst, Lab Memory & Learning, Wako, Saitama, Japan
[5] Tokyo Womens Med Univ, Inst Clin Endocrinol, Tokyo, Japan
关键词
subtle alternative splicing; splice acceptors; polyglutamine diseases; DRPLA; subcellular localization;
D O I
10.1007/s10038-005-0261-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Protein isoforms with or without a single amino acid residue make a subtle difference. It has been documented on a few genes that alternative splicing generated such isoforms; however, the fact has attracted little attention. We became aware of a subtle sequence difference in DRPLA, a polyglutamine disease gene for dentatorubral pallidoluysian atrophy. Some reported cDNA sequences lacked 3 nucleotides (nt) (CAG), which were positioned apart from the expandable and polymorphic CAG repeats and also coded for glutamine. We experimentally confirmed that the difference was indeed generated by alternative splicing utilizing two acceptors separated by 3 nt. In DRPLA, the expression ratio of two mRNA isoforms was almost constant among tissues, with the CAG-included form being major. The glutamine-included protein isoform was more predominantly localized in the nucleus. Database searching revealed that alternative splice acceptors, as well as donors, are frequently situated very close to each other. We experimentally confirmed two mRNA isoforms of 3 nt difference in more than 200 cases by RT-PCR and found interesting features associated with this phenomena. Inclusion of 3 nt tends to result in single amino acid inclusion despite the phase of translational frame. The expression ratio sometimes varied extensively among tissues.
引用
收藏
页码:382 / 394
页数:13
相关论文
共 39 条
[1]   Mechanisms of alternative pre-messenger RNA splicing [J].
Black, DL .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :291-336
[2]   An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing [J].
Chua, K ;
Reed, R .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1509-1514
[3]   Finishing the euchromatic sequence of the human genome [J].
Collins, FS ;
Lander, ES ;
Rogers, J ;
Waterston, RH .
NATURE, 2004, 431 (7011) :931-945
[4]  
CONDORELLI G, 1994, J BIOL CHEM, V269, P8510
[5]   Trinucleotide repeats: Mechanisms and pathophysiology [J].
Cummings, CJ ;
Zoghbi, HY .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2000, 1 :281-328
[6]   Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity [J].
Ellerby, LM ;
Andrusiak, RL ;
Wellington, CL ;
Hackam, AS ;
Propp, SS ;
Wood, JD ;
Sharp, AH ;
Margolis, RL ;
Ross, CA ;
Salvesen, GS ;
Hayden, MR ;
Bredesen, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :8730-8736
[7]   Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs [J].
Forman, MS ;
Trojanowski, JQ ;
Lee, VMY .
NATURE MEDICINE, 2004, 10 (10) :1055-1063
[8]   Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity [J].
Hiller, M ;
Huse, K ;
Szafranski, K ;
Jahn, N ;
Hampe, J ;
Schreiber, S ;
Backofen, R ;
Platzer, M .
NATURE GENETICS, 2004, 36 (12) :1255-1257
[9]   Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch [J].
Igarashi, S ;
Koide, R ;
Shimohata, T ;
Yamada, M ;
Hayashi, Y ;
Takano, H ;
Date, H ;
Oyake, M ;
Sato, T ;
Sato, A ;
Egawa, S ;
Ikeuchi, T ;
Tanaka, H ;
Nakano, R ;
Tanaka, K ;
Hozumi, I ;
Inuzuka, T ;
Takahashi, H ;
Tsuji, S .
NATURE GENETICS, 1998, 18 (02) :111-117
[10]   Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease [J].
Kanazawa, I .
NEUROGENETICS, 1998, 2 (01) :1-17